Procedure conclusiveness | | | | | |
Conclusive pathology results following one TTLB | 474 | | | | <10-4 |
Yes | | 376 (79.3) | 140 (70.7) | 236 (85.5) | |
No | | 98 (20.7) | 58 (29.3) | 40 (14.5) | |
Diagnosis of malignancy in conclusive first TTLB | 376 | | | | 0.255 |
Yes | | 334 (88.8) | 121 (86.4) | 213 (90.3) | |
No | | 42 (11.2) | 19 (13.6) | 23 (9.7) | |
Performance for malignancy diagnosis following first TTLB | | | | | |
Sensitivity/recall (%) | | 89.5 | 84.0 | 93.0 | NA |
Specificity/selectivity (%) | | 100 | 100 | 100 | |
Accuracy (%) | | 91.8 | 88.4 | 94.2 | |
PPV (%) | | 100 | 100 | 100 | |
NPV (%) | | 72.1 | 70.1 | 74.6 | |
F1 score (%) | | 94.5 | 91.3 | 96.4 | |
Complications | | | | | |
PTX occurrence | 474 | | | | <10-5 |
Yes | | 134 (28.3) | 78 (39.4) | 56 (20.3) | |
No | | 340 (71.7) | 120 (60.6) | 220 (79.7) | |
PTX requiring chest tube drainage | 474 | | | | 0.023 |
Yes | | 1 (6.5) | 19 (9.6) | 12 (4.3) | |
No | | 443 (93.5) | 179 (90.4) | 264 (95.7) | |
IAH occurrence | 474 | | | | <10-10 |
Yes | | 123 (25.9) | 81 (40.9) | 42 (15.2) | |
No | | 351 (74.1) | 117 (59.1) | 234 (84.8) | |
Haemoptysis occurrence | 461 (13) | | | | 0.032 |
Yes | | 20 (4.3) | 13 (6.7) | 7 (2.6) | |
No | | 441 (95.7) | 180 (93.3) | 261 (97.4) | |
Length of stay in patients planned as outpatient procedures (days) | 368±6 | 2.3±6.4 | 1.9±2.6 | 2.6±0.6 | 0.054 |
Extended stay duration due to PTX in outpatient procedures | 368 (6) | | | | 0.002 |
Yes | | 42 (11.4) | 27 (17.4) | 15 (7.0) | |
No | | 326 (88.6) | 128 (82.6) | 198 (93.0) | |